Skip to main content
  • Clinical Utility and Accuracy of MR Spectroscopy in Diagnosing Solitary Brain Lesions

    Final Number:
    1328

    Authors:
    Menarvia K. C. Nixon MD; Prashant Chittiboina MD, MPH; Anil Nanda MD FACS; Bharat Guthikonda MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: To address the diagnostic challenge of differentiating non-neoplastic, metastatic and primary brain lesions magnetic resonance spectroscopy (MRS) was created to improve diagnostic accuracy. The purpose of this study is to evaluate the diagnostic accuracy of MRS at a single institution and thus its clinical utility in the treatment of brain lesions.

    Methods: A retrospective analysis of all MR spectroscopy examinations from 2006 – 2011 at LSUHSC was conducted. Inclusion criteria consisted of availability of MRI and MRS imaging, surgical pathology results either by biopsy, resection and/or CSF analysis and MRS imaging prior to obtaining tissue sample. Patients were excluded on the basis of MRS for differentiation of tumor recurrence versus radiation necrosis.

    Results: The search for MR spectroscopy examinations yielded 74 patients. Eleven patients were excluded due to previous resection and eight patients were excluded due to unavailability of tissue pathology. Of the 55 patients included in the study, tissue pathology revealed 30 patients with primary brain lesions, 10 patients with metastatic lesions, 12 patients with demyelinating lesions, 2 abscesses and 1 hematoma. Of the 30 patients with tissue diagnosis of primary brain lesions, 22 patients had an MRS report concluding primary neoplasm, 3 concluding neoplasm without distinction of primary vs. metastatic lesion, 3 stating metastatic lesion, 2 reporting inflammatory process. Of the 10 metastatic lesions, 8 were reported as metastatic and 2 as primary lesions. All demyelinating lesions and abscesses were reported by MRS as such. Calculated sensitivity of MRS for primary vs. metastatic lesions was 88% and specificity was 80%; positive predictive value was 92%. Calculated sensitivity for neoplastic vs non-neoplastic lesions was 92.8%, specificity and positive predictive value were 100%.

    Conclusions: The results of this study illustrate that MRS is a useful tool in classifying solitary brain lesions and can assist in decreasing the need for biopsy.

    Patient Care: Improve diagnosis of solitary brain lesions and decrease the need for biopsy.

    Learning Objectives: By the conclusion of this session, participants should be: 1. Aware of the clinical utility and diagnostic accuracy of MR spectroscopy in solitary brain lesions 2. Consider use of MR spectroscopy in their practice for diagnosing solitary brain lesions

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy